COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 18.25 |
| 52 Week High | 18.90 |
| 52 Week Low | 11.62 |
| Avg. Daily Vol. (Mil) | 52.19 |
| Beta (3 year) | 0.73 |
| Share Related Items | |
| Mkt Cap (Mil) | 147,269.03 |
| Shares Out (Mil) | 8,069.54 |
| Float (Mil) | 6,744.78 |
| Dividend Information | |
| Yield % | 3.50 |
| Annual Dividend | 0.64 |
| Payout Ratio | 79.00 |
| Financial Strength | |
| Quick Ratio | 2.70 |
| Current Ratio | 3.10 |
| LT Debt/ Equity | 0.59 |
| Total Debt / Equity | 0.70 |
| Valuation Ratios | |
| Price Earnings | 15.10 |
| Price/Sales | 3.21 |
| Price/Book | 2.23 |
| Price/Cash Flow | 12.00 |
| Per Share Data | |
| Earnings | 1.21 |
| Sales | 5.68 |
| Book Value | 8.19 |
| Cash Flow | 1.52 |
| Business Summary | |
|---|---|
| A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals. | |
| General Information | |
| 235 East 42nd Street
New York, NY 10017-5755 |
|
| www.pfizer.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 81800 | |
| CEO: Jeffrey B. Kindler | |
| Short Interest | |
| Current Month (Mil) | 48.96 |
| Previous Month (Mil) | 55.34 |
| Short Interest Ratio (Days) | 0.80 |
| Management Effectiveness | |
| Return on Equity | 12.30 |
| Return on Assets | 5.80 |
| Return on Investments | 7.70 |
| Profitability | |
| Gross Margin | 89.40 |
| EBIT Margin | 26.10 |
| Profit Margin | 17.80 |